163 related articles for article (PubMed ID: 31691294)
1. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
[TBL] [Abstract][Full Text] [Related]
2. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
[TBL] [Abstract][Full Text] [Related]
3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
4. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
5. Evidence of increasing mortality with longer time to diagnosis of cancer: is there a paediatric exception?
Brasme JF; Grill J; Gaspar N; Oberlin O; Valteau-Couanet D; Chalumeau M
Eur J Cancer; 2014 Mar; 50(4):864-6. PubMed ID: 24388772
[No Abstract] [Full Text] [Related]
6. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
Ferlay J; Steliarova-Foucher E; Lortet-Tieulent J; Rosso S; Coebergh JW; Comber H; Forman D; Bray F
Eur J Cancer; 2013 Apr; 49(6):1374-403. PubMed ID: 23485231
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
8. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
9. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.
Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P
Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
Depczynski J; Dobbins T; Armstrong B; Lower T
BMC Cancer; 2018 Jan; 18(1):33. PubMed ID: 29304761
[TBL] [Abstract][Full Text] [Related]
11. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003.
Wild SH; Fischbacher CM; Brock A; Griffiths C; Bhopal R
Br J Cancer; 2006 Apr; 94(7):1079-85. PubMed ID: 16523198
[TBL] [Abstract][Full Text] [Related]
12. Estimating the magnitude of cancer overdiagnosis in Australia.
Glasziou PP; Jones MA; Pathirana T; Barratt AL; Bell KJ
Med J Aust; 2020 Mar; 212(4):163-168. PubMed ID: 31858624
[TBL] [Abstract][Full Text] [Related]
13. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
14. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
16. The importance of age in screening for cancer.
Law MR; Morris JK; Wald NJ
J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
[TBL] [Abstract][Full Text] [Related]
17. Leading cancers--changes in five-year relative survival.
Ellison LF; Gibbons L
Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
[TBL] [Abstract][Full Text] [Related]
18. Estimates of cancer burden in Trentino-Alto Adige.
Piffer S; Gentilini M; Rizzello R; Mazzoleni G; Bellù F; Rossi S
Tumori; 2013; 99(3):296-307. PubMed ID: 24158058
[TBL] [Abstract][Full Text] [Related]
19. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
20. Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002.
Elstad JI; Torstensrud R; Lyngstad TH; Kravdal O
Eur J Public Health; 2012 Dec; 22(6):771-6. PubMed ID: 22167478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
